Study of T Cell Phenotype Activation Pathway in Human Alcoholic Liver Disease

This study has been completed.

Sponsor:

Information provided by:

Erasme University Hospital

ClinicalTrials.gov Identifier:

NCT00610597

First received: January 28, 2008

Last updated: NA

Last verified: January 2008

History: No changes posted

Full Text View
Tabular View
No Study Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	January 2008
Primary Completion Date:	January 2007 (Final data collection date for primary outcome measure)

No publications provided by Erasme University Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Lemmers A, Moreno C, Gustot T, Maréchal R, Degré D, Demetter P, de Nadai P, Geerts A, Quertinmont E, Vercruysse V, Le Moine O, Devière J. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology. 2009 Feb;49(2):646-57.

To Top